India continues to rediscover the power of Ayurveda, and many startups now bring this ancient wisdom to modern families. Among them, BabyOrgano stands out. The Ahmedabad-based brand focuses on children’s health and wellness through chemical-free Ayurvedic products. BabyOrgano recently raised ₹20 crore in a Pre-Series A funding round led by RPSG Capital Ventures, along with existing investor Sauce.vc. This new investment gives the brand the resources to build stronger products, expand across markets, and chase its bold goal of ₹100 crore in revenue by FY27.
A Vision Rooted in Parenthood
Riddhi and Ripul Sharma founded BabyOrgano in 2020 after they noticed a major issue in the Indian childcare market. Many parents struggled to find safe, trustworthy wellness products for their children. Most products on shelves contained chemicals or preservatives. Parents wanted natural alternatives, but they could not always trust homemade remedies or unverified traditional recipes. Riddhi and Ripul stepped in to fill this gap.
They turned to Ayurveda. They believed Ayurveda could offer safe, scientifically validated solutions for children’s immunity, digestion, growth, and overall well-being. Riddhi took inspiration from her own journey as a mother. She wanted natural remedies for her children but also needed clinical validation, proper measurements, and consistency. BabyOrgano grew from this blend of traditional wisdom and modern parenting needs.
Funding That Fuels Growth
RPSG Capital Ventures led the new funding round and showed strong confidence in BabyOrgano’s mission. Sauce.vc, an existing investor, joined them again. The new ₹20 crore investment gives BabyOrgano financial strength and strategic backing. RPSG Capital Ventures, part of the RP-Sanjiv Goenka Group, brings experience in consumer brands and wellness markets, while Sauce.vc contributes strong expertise in early-stage growth and brand building.
Riddhi and Ripul plan to use the funds to strengthen product innovation, expand marketing efforts, and increase offline distribution. BabyOrgano wants to reach more Indian homes, not only through e-commerce platforms but also through pharmacies, wellness stores, and pediatric clinics. The company has already set a revenue target of ₹100 crore by FY27, and this funding pushes it closer to that milestone.
A Unique Product Offering
BabyOrgano builds its identity around natural, chemical-free, and child-safe products. All products follow Ayurvedic principles, but the brand also ensures clinical testing and certification for safety and effectiveness. This balance helps the company gain trust from modern parents who want both tradition and science.
One of BabyOrgano’s flagship products, the Baalprashan Swarnaprashan Drops, gained significant attention. It represents India’s first clinically approved Swarnaprashan for children. In Ayurveda, Swarnaprashan refers to a preparation made with gold, herbs, honey, and ghee. It supports immunity, memory, digestion, and brain development. Many Indian families used Swarnaprashan traditionally, but BabyOrgano brought it into a scientifically structured format with precise dosage and testing.
Parents across India now use Baalprashan Swarnaprashan Drops for improving their children’s immunity and cognitive growth. The brand also sells products for digestion, cold and cough relief, teething discomfort, and sleep issues. It avoids artificial colors, preservatives, parabens, or harmful chemicals in its formulations.
A Market Ready for Change
India’s wellness and childcare markets continue to grow at a rapid pace. More parents turn to natural and herbal products as concerns over chemical-based products rise. Surveys show that parents, especially millennial and Gen Z parents, now research ingredients, check certifications, and read reviews before buying anything for their children. They trust brands that offer transparency, authenticity, and proven results.
BabyOrgano understands this shift. The company focuses on clean-label packaging, honest communication, and educational content. It shares details about ingredients, benefits, and usage instructions. It also collaborates with pediatricians and Ayurveda practitioners to build credibility. Many parents appreciated this approach because it reduces confusion and fear around children’s healthcare choices.
Thoughts from Investors and Founders
Abhishek Goenka from RPSG Capital Ventures spoke about BabyOrgano’s strategic position. He noted that the brand sits at the intersection of Ayurveda and safe, science-backed childcare. He believes BabyOrgano taps into a market where families want natural solutions but also expect clinical assurance.
Riddhi Sharma shared her excitement after the funding announcement. She said the new capital will help BabyOrgano reach more parents and create innovative wellness solutions for children. She emphasized her mission to make Ayurvedic childcare simple, accessible, and trustworthy. Ripul added that they will strengthen supply chains, improve customer experience, and hire top talent to support their expansion.
Expanding Beyond Online Markets
So far, BabyOrgano has grown mainly through online channels like Amazon, Flipkart, FirstCry, and its own website. However, many Indian parents still prefer buying healthcare products from offline stores. They want to talk to pharmacists or doctors before purchasing. BabyOrgano plans to tap into this offline retail potential by setting up distribution networks in major cities and tier-2 and tier-3 towns.
The company aims to partner with pediatric clinics, Ayurvedic practitioners, wellness centers, and maternity hospitals. This move will help BabyOrgano create direct trust with parents through medical experts. It also wants to set up educational workshops and product demos to inform parents about the benefits of Ayurvedic childcare.
Innovation as a Growth Driver
Product innovation forms a core part of BabyOrgano’s future strategy. The company continues to invest in research and development. It works with Ayurvedic scholars, doctors, and formulation experts to design new products for immunity, digestion, skin care, oral care, and growth problems in children.
BabyOrgano also invests in manufacturing technology to ensure hygiene, accuracy, and consistency. It follows Good Manufacturing Practices (GMP) and quality testing at every stage. It collects feedback from parents and uses it to refine its products. This constant innovation keeps the brand relevant in a highly competitive market.
Challenges and Opportunities Ahead
BabyOrgano faces competition from both traditional Ayurvedic brands and modern natural-wellness startups. Brands like Dabur, Himalaya, and Baidyanath enjoy long-standing trust, while newer startups like Mamaearth, Mother Sparsh, and The Moms Co bring modern aesthetics and influencer-driven marketing. BabyOrgano needs to maintain its unique identity and continue building trust through quality.
However, the opportunity ahead looks huge. India has a large young population. Parents in urban and semi-urban areas spend more on wellness and preventive care. Government support for Ayurveda also creates a positive environment for brands like BabyOrgano.
Conclusion
BabyOrgano’s journey shows how ancient wisdom and modern science can work together. Riddhi and Ripul Sharma built a brand that answers a real problem: the need for safe, trusted, and effective wellness products for children. With ₹20 crore in fresh funding, strong investor support, and a clear mission, BabyOrgano now prepares to scale across India and beyond. The brand dreams of a future where every Indian parent can choose natural, reliable care for their children—without fear or doubt.
Also Read – Turbostart Opens New Delhi Office to Boost Startup Growth